Somerset Trust Co trimmed its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.6% in the third quarter, according to its ...

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Amgen (AMGN – Research Report) today and set a price target of $319.00.

On October 4, 2024, Deep Track Capital, LP (Trades, Portfolio) marked a significant portfolio addition by acquiring 68,415.6 ...

Imuldosa is the latest FDA-approved biosimilar of J&J’s blockbuster therapy for the treatment of certain autoimmune diseases.

The Dow Jones Industrial Average and the other major stock indexes traded lower Friday as investors reacted to more inflation ...

Caleb Carr’s company started in a garage when he was a student at the University of Colorado Denver. He was 18 years old but ...

Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...